Merck KGaA announced the appointment of Hong Chow to its Healthcare business sector as head of China International with effect from 1 October 2021. Based in Shanghai, China, Chow will lead China and Japan as well the regions Europe, Latin America, Asia-Pacific and Middle East, Africa and Russia, the franchise of Cardiovascular Metabolism Endocrinology (CME) and the Global Business Innovation team. She will serve as a member of the Healthcare Executive Committee and will report to Peter Guenter, member of the Executive Board of Merck and CEO Healthcare. Currently, Chow is CEO of Roche Pharmaceuticals in China as well as a member of the Supervisory Board at Beiersdorf AG.